Day One Biopharma Files 8-K on Shareholder Vote Matters
Ticker: DAWN · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1845337
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Day One Biopharma is holding a shareholder vote.
AI Summary
On June 2, 2025, Day One Biopharmaceuticals, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing, made on June 3, 2025, pertains to corporate governance and shareholder decisions.
Why It Matters
This filing indicates that Day One Biopharmaceuticals is engaging its shareholders in important corporate decisions, which can impact the company's direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine procedural report regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Day One Biopharmaceuticals, Inc. (company) — Registrant
- June 2, 2025 (date) — Date of earliest event reported
- June 3, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-40431 (company_id) — Commission File Number
- 83-2415215 (ein) — IRS Employer Identification No.
- 1800 Sierra Point Parkway, Suite 200 (address) — Address of principal executive offices
- Brisbane, California (location) — Principal executive offices location
- 94005 (zip_code) — Principal executive offices zip code
- (650) 484-0899 (phone_number) — Registrant's telephone number
FAQ
What specific matters are being submitted for a vote of security holders?
The filing states that the report is for the 'Submission of Matters to a Vote of Security Holders,' but the specific details of these matters are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 2, 2025.
What is the Commission File Number for Day One Biopharmaceuticals, Inc.?
The Commission File Number is 001-40431.
Where are Day One Biopharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 1800 Sierra Point Parkway, Suite 200, Brisbane, California 94005.
What is the IRS Employer Identification Number for the company?
The IRS Employer Identification Number is 83-2415215.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Day One Biopharmaceuticals, Inc. (DAWN).